
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
ARID1B CRISPR/Cas9 KO Plasmid (m) | sc-433726 | 20 µg | $397.00 |
Arid1b encodes ARID1B, an AT-rich interaction domain–containing subunit of the SWI/SNF (BAF) ATP-dependent chromatin remodeling complex that regulates nucleosome positioning and enhancer accessibility. Through control of chromatin state, ARID1B influences transcriptional programs governing cell fate specification, proliferation, and differentiation, with prominent roles in neural development and lineage-restricted gene expression. ARID1B participates in epigenetic regulation that interfaces with pathways such as Wnt/β-catenin, Notch, and cell-cycle control, shaping context-dependent transcriptional outputs. Disruption of ARID1B function has been linked to developmental disorders and neurodevelopmental phenotypes, and altered SWI/SNF composition is frequently studied in disease-relevant models of transcriptional dysregulation.
ARID1B CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Arid1b gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Arid1b together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Arid1b open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish ARID1B protein expression.
This CRISPR knockout system enables efficient generation of Arid1b-deficient cell models for investigation of ARID1B signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.